Treatment of nonocular infections in AIDS.
Palestine
A G
AG
Laboratory of Immunology, National Eye Institute, Bethesda, MD 20892.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000945:Antigens, Differentiation, T-Lymphocyte / Q000008:administration & dosage / Q000378:metabolism; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D015699:HIV Envelope Protein gp120; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D009164:Mycobacterium Infections / Q000188:drug therapy; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy; D011485:Protein Binding; D011991:Receptors, Virus / Q000378:metabolism; D012191:Retroviridae Proteins / Q000276:immunology / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors; D014123:Toxoplasmosis / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000998:Antiviral Agents; D015699:HIV Envelope Protein gp120; D011991:Receptors, Virus; D012191:Retroviridae Proteins; D018894:Reverse Transcriptase Inhibitors